Top Clinical Trials companies in Hong Kong by Shares (Diluted, Weighted)

This ranking features the top 7 Clinical Trials companies in Hong Kong ranked by Shares (Diluted, Weighted), averaging a Shares (Diluted, Weighted) of 663,738,981, for February 03, 2025.
#
Name
Shares (Diluted, Weighted)
Reported Date
Stock Price
Change
Price (30 days) Country
1
2,069,710,308
Dec. 31, 2023 USD 0.22 -1.18%

Hong Kong

2
1,018,115,585
Dec. 31, 2023 USD 0.13 -0.02%

Hong Kong

3
869,196,348
Dec. 31, 2023 USD 2.68 -1.44%

Hong Kong

4
588,836,000
Dec. 31, 2023 USD 0.16 -3.21%

Hong Kong

5
76,055,750
Dec. 31, 2023 USD 0.37 4.31%

Hong Kong

6
13,012,866
June 30, 2024 USD 3.80 0.53%

Hong Kong

7
11,246,010
Dec. 31, 2023 USD 5.25 -2.96%

Hong Kong

Frequently Asked Questions
  • Which Clinical Trials company in Hong Kong has the highest Shares (Diluted, Weighted) ?

    The Clinical Trials company in Hong Kong with the highest Shares (Diluted, Weighted) is Frontage Holdings Corporation (HKSE: 1521.HK) at 2,069,710,308.

  • Which Clinical Trials company in Hong Kong has the lowest Shares (Diluted, Weighted) ?

    The Clinical Trials company in Hong Kong with the lowest Shares (Diluted, Weighted) is Prenetics Global Limited (NasdaqGM: PRE) at 11,246,010.

SV Wall Street